Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

E. Bajetta,M. Di Bartolomeo,R. Buzzoni,L. Mariani,Nicoletta Zilembo,Erminia Ferrario,S. Lo Vullo,E. Aitini,L Isa,Carlo Barone,S. Jacobelli,E Recaldin,Graziella Pinotti,A. Iop

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

2007

E. Bajetta
M. Di Bartolomeo
R. Buzzoni
L. Mariani
Nicoletta Zilembo
Erminia Ferrario
S. Lo Vullo
E. Aitini
L Isa
Carlo Barone
S. Jacobelli
E Recaldin
Graziella Pinotti
A. Iop

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

Keywords:

Immunology
Pathology
Colorectal cancer
Cancer
Phases of clinical research
Medicine
Oxaliplatin
Metastasis
Irinotecan
Tegafur
Camptothecin
Randomization
Neutropenia
Adverse effect

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations